A promising pipeline alone isn't enough anymore to ensure a successful medical device IPO. S2N's Amy Siegel examines what it takes to create a successful public trading debut in medtech.
Click image to enlarge
Intersect ENT Inc., Lombard Medical Technologies, Ocular Therapeutix Inc., S2N Health, T2 Biosystems Inc., TriVascular
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/YzsX9N
Cap comentari:
Publica un comentari a l'entrada